Revolution Medicines, Inc.
RVMD
$149.94
$4.222.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -96.66% | -88.52% | -69.47% | -56.40% | -44.03% |
| Total Depreciation and Amortization | 43.68% | 46.01% | 38.72% | 34.02% | 38.37% |
| Total Amortization of Deferred Charges | -45.45% | -18.18% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 429.06% | 327.84% | 139.20% | 94.18% | 29.42% |
| Change in Net Operating Assets | 34.73% | 21,284.98% | 572.17% | 250.60% | 766.35% |
| Cash from Operations | -78.83% | -61.05% | -41.15% | -34.35% | -31.77% |
| Capital Expenditure | -37.04% | -55.12% | -34.06% | -48.38% | -13.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 202.86% | 124.64% | 36.96% | 12.03% | 46.71% |
| Cash from Investing | 195.11% | 121.29% | 35.46% | 10.61% | 45.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -28.78% | -56.34% | 795.84% | 7,168.69% | 1,151.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 155.21% | 155.40% | -59.57% | -58.89% | -88.62% |
| Cash from Financing | -10.43% | -35.22% | 22.13% | 42.40% | 5.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.05% | -3.77% | 111.59% | 222.49% | 133.30% |